UNSPSC 51203801: Abatacept

This classification denotes an immunosuppressant with the molecular formula C1965H3080N479O695S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7D0YB67S97, more generally known as abatacept. European Medicines Agency schedules abatacept in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20635. The term ABATACEPT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, list 53.

UNSPSC 51203801 Abatacept is a Commodity code nominally referencing a specific immunosuppressant pharmaceutical, but the recent state and local opportunities posted under this code show no procurement activity aligned with abatacept itself. Instead, the code has been applied to broader pharmaceutical and medical supply solicitations spanning naloxone distribution, direct-to-manufacturer prescription programs, emergency medical supplies for fire departments, and generic multi-source pharmaceutical contracts. The mismatch between the code's nominal scope and actual procurement activity suggests the code is either being misapplied by issuing bodies or represents a catch-all category for pharmaceutical and medical supply contracting. State and local agencies soliciting under this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and cooperative purchasing alliances serving multi-state government jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP).

Recent activity concentrates in Florida, Texas, and the Upper Midwest region covered by MMCAP. The most recent solicitation is Seminole County, Florida's IFB 60459723LAS, due July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county's community health building. The City of Tampa issued IFB 26P00145 in March 2026 for medical and first aid supplies ($700,000 estimated contract value) for the Tampa Fire Department Rescue Division, designated as a sheltered-market procurement for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas HHS Commission posted RFI HHS0017013 in April 2026 to solicit vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program. MMCAP issued RFP S1070000015802 in January 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed to participating state and local facilities across Minnesota and Oregon, with award effective July 1, 2026.